vs
Esperion Therapeutics, Inc.（ESPR）与Liberty Broadband Corp（LBRDA）财务数据对比。点击上方公司名可切换其他公司
Liberty Broadband Corp的季度营收约是Esperion Therapeutics, Inc.的1.5倍（$261.0M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 6.1%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 4.3%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
本公司是一家覆盖英、荷、美三地的跨国电信企业，注册地为百慕大，在伦敦、阿姆斯特丹、丹佛设有总部，旗下拥有多家对应司法辖区的运营主体，其中英国主体为公开上市实体，2005年由自由媒体国际业务板块与UnitedGlobalCom合并成立。
ESPR vs LBRDA — 直观对比
营收规模更大
LBRDA
是对方的1.5倍
$168.4M
营收增速更快
ESPR
高出137.6%
6.1%
两年增速更快
ESPR
近两年复合增速
4.3%
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $261.0M |
| 净利润 | — | $383.0M |
| 毛利率 | — | — |
| 营业利润率 | 50.6% | 15.7% |
| 净利率 | — | 146.7% |
| 营收同比 | 143.7% | 6.1% |
| 净利润同比 | — | 96.4% |
| 每股收益（稀释后） | $0.32 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRLBRDA
| Q4 25 | $168.4M | — | ||
| Q3 25 | $87.3M | — | ||
| Q2 25 | $82.4M | $261.0M | ||
| Q1 25 | $65.0M | $266.0M | ||
| Q4 24 | $69.1M | $263.0M | ||
| Q3 24 | $51.6M | $262.0M | ||
| Q2 24 | $73.8M | $246.0M | ||
| Q1 24 | $137.7M | $245.0M |
净利润ESPRLBRDA
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | — | ||
| Q2 25 | $-12.7M | $383.0M | ||
| Q1 25 | $-40.5M | $268.0M | ||
| Q4 24 | — | $291.0M | ||
| Q3 24 | $-29.5M | $142.0M | ||
| Q2 24 | $-61.9M | $195.0M | ||
| Q1 24 | $61.0M | $241.0M |
营业利润率ESPRLBRDA
| Q4 25 | 50.6% | — | ||
| Q3 25 | -11.4% | — | ||
| Q2 25 | 8.6% | 15.7% | ||
| Q1 25 | -34.0% | 16.2% | ||
| Q4 24 | -6.4% | 4.9% | ||
| Q3 24 | -31.0% | 11.5% | ||
| Q2 24 | 3.5% | 8.5% | ||
| Q1 24 | 52.5% | 11.4% |
净利率ESPRLBRDA
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | — | ||
| Q2 25 | -15.4% | 146.7% | ||
| Q1 25 | -62.2% | 100.8% | ||
| Q4 24 | — | 110.6% | ||
| Q3 24 | -57.2% | 54.2% | ||
| Q2 24 | -83.9% | 79.3% | ||
| Q1 24 | 44.3% | 98.4% |
每股收益（稀释后）ESPRLBRDA
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.06 | $2.68 | ||
| Q1 25 | $-0.21 | $1.87 | ||
| Q4 24 | $-0.14 | $2.04 | ||
| Q3 24 | $-0.15 | $0.99 | ||
| Q2 24 | $-0.33 | $1.36 | ||
| Q1 24 | $0.34 | $1.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $180.0M |
| 总债务越低越好 | — | $3.1B |
| 股东权益账面价值 | $-302.0M | $10.4B |
| 总资产 | $465.9M | $16.6B |
| 负债/权益比越低杠杆越低 | — | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资ESPRLBRDA
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | $180.0M | ||
| Q1 25 | $114.6M | $226.0M | ||
| Q4 24 | $144.8M | $163.0M | ||
| Q3 24 | $144.7M | $168.0M | ||
| Q2 24 | $189.3M | $73.0M | ||
| Q1 24 | $226.6M | $108.0M |
总债务ESPRLBRDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $3.1B | ||
| Q1 25 | — | $3.8B | ||
| Q4 24 | — | $3.8B | ||
| Q3 24 | — | $3.7B | ||
| Q2 24 | — | $3.6B | ||
| Q1 24 | — | $3.6B |
股东权益ESPRLBRDA
| Q4 25 | $-302.0M | — | ||
| Q3 25 | $-451.4M | — | ||
| Q2 25 | $-433.5M | $10.4B | ||
| Q1 25 | $-426.2M | $10.1B | ||
| Q4 24 | $-388.7M | $9.8B | ||
| Q3 24 | $-370.2M | $9.5B | ||
| Q2 24 | $-344.2M | $9.3B | ||
| Q1 24 | $-294.3M | $9.1B |
总资产ESPRLBRDA
| Q4 25 | $465.9M | — | ||
| Q3 25 | $364.0M | — | ||
| Q2 25 | $347.1M | $16.6B | ||
| Q1 25 | $324.0M | $17.0B | ||
| Q4 24 | $343.8M | $16.7B | ||
| Q3 24 | $314.1M | $16.3B | ||
| Q2 24 | $352.3M | $16.0B | ||
| Q1 24 | $373.1M | $15.7B |
负债/权益比ESPRLBRDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.30× | ||
| Q1 25 | — | 0.38× | ||
| Q4 24 | — | 0.38× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.39× | ||
| Q1 24 | — | 0.40× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $91.0M |
| 自由现金流经营现金流 - 资本支出 | — | $37.0M |
| 自由现金流率自由现金流/营收 | — | 14.2% |
| 资本支出强度资本支出/营收 | 0.0% | 20.7% |
| 现金转化率经营现金流/净利润 | — | 0.24× |
| 过去12个月自由现金流最近4个季度 | — | $-49.0M |
8季度趋势，按日历期对齐
经营现金流ESPRLBRDA
| Q4 25 | $45.2M | — | ||
| Q3 25 | $-4.3M | — | ||
| Q2 25 | $-31.4M | $91.0M | ||
| Q1 25 | $-22.6M | $78.0M | ||
| Q4 24 | $-35.0M | $1.0M | ||
| Q3 24 | $-35.3M | $24.0M | ||
| Q2 24 | $-7.2M | $27.0M | ||
| Q1 24 | $53.8M | $52.0M |
自由现金流ESPRLBRDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $37.0M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $-63.0M | ||
| Q3 24 | $-35.5M | $-36.0M | ||
| Q2 24 | $-7.3M | $-35.0M | ||
| Q1 24 | $53.8M | $-9.0M |
自由现金流率ESPRLBRDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 14.2% | ||
| Q1 25 | — | 4.9% | ||
| Q4 24 | — | -24.0% | ||
| Q3 24 | -68.7% | -13.7% | ||
| Q2 24 | -9.9% | -14.2% | ||
| Q1 24 | 39.0% | -3.7% |
资本支出强度ESPRLBRDA
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | 20.7% | ||
| Q1 25 | 0.0% | 24.4% | ||
| Q4 24 | 0.0% | 24.3% | ||
| Q3 24 | 0.3% | 22.9% | ||
| Q2 24 | 0.1% | 25.2% | ||
| Q1 24 | 0.1% | 24.9% |
现金转化率ESPRLBRDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.17× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | 0.88× | 0.22× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
LBRDA
暂无分部数据
